In today’s recent session, 2.87 million shares of the GSK Plc ADR (NYSE:GSK) have been traded, and its beta is 0.66. Most recently the company’s share price was $33.43, and it changed around -$0.26 or -0.77% from the last close, which brings the market valuation of the company to $68.18B. GSK at last check was trading at a discount to its 52-week high of $45.92, offering almost -37.36% off that amount. The share price’s 52-week low was $32.83, which indicates that the recent value has risen by an impressive 1.79% since then. We note from GSK Plc ADR’s average daily trading volume that its 10-day average is 9.43 million shares, with the 3-month average coming to 5.39 million.
GSK Plc ADR stock received a consensus recommendation rating of Hold, based on a mean score of 2.50. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 3 recommended GSK as a Hold, whereas 2 deemed it a Buy, and 1 rated it as Underweight. GSK Plc ADR is expected to report earnings per share of 0.44 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GSK Plc ADR (NYSE:GSK) trade information
Instantly GSK has been showing red trend so far today with a performance of -0.77% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 35.46 on recent trading dayincreased the stock’s daily price by 5.72%. The company’s shares are currently down -9.80% year-to-date, but still down -5.89% over the last five days. On the other hand, GSK Plc ADR (NYSE:GSK) is -12.40% down in the 30-day period. We can see from the shorts that 16.29 million shares have been sold at a short interest cover period of 3.29 day(s).
The consensus price target as assigned by Wall Street analysts is $53, which translates to bulls needing to increase their stock price by 36.92% from its current value. Analyst projections state that GSK is forecast to be at a low of $36 and a high of $85.
GSK Plc ADR (GSK) estimates and forecasts
GSK Plc ADR share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -24.81 percent over the past six months and at a 5.96% annual growth rate that is well below the industry average of 17.80%. The year-over-year growth rate is expected to be 3.77%, up from the previous year.
Consensus estimates provided by 5 financial analysts predict the company will bring in an average of 7.64B in revenue for the current quarter. 17 analysts expect GSK Plc ADR to make 31.27B in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 8.05B and 30.33B respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -5.07%. Forecasts for the next quarter put sales growth at 3.11%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 4.23%. GSK Plc ADR earnings are expected to increase by 1.77% in 2024, but the outlook is positive 5.22% per year for the next five years.
GSK Dividends
GSK Plc ADR’s next quarterly earnings report is expected to be released on 2025-Feb-05. The annual dividend yield of the stock is 4.70 percent and its annual dividend per share was 1.57. It is important to note, however, that the 4.70% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision. The average dividend yield for the past five years averaged 4.83 per year.
GSK Plc ADR (NYSE:GSK)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.06% of GSK Plc ADR shares, and 15.38% of them are in the hands of institutional investors. The stock currently has a share float of 15.39%. GSK Plc ADR stock is held by 1024.0 institutions, with DODGE & COX being the largest institutional investor. By 2024-06-30, it held 1.6795% of the shares, which is about 68.34 million shares worth $2.63 billion.
FMR LLC, with 0.6583% or 26.78 million shares worth $1.03 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
